Cemsidomide

Generic Name: Cemsidomide

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₈H_₂₇N_₃O_₄

CAS Number: 2504235-67-8

Unique Ingredient Identifier: D86MF5H9WJ

Associated Conditions: -

Associated Therapies: -

Clinical Trials

C4 Therapeutics Presents Cemsidomide Phase 1 Data at the American Society ...

The article discusses the importance of enabling JavaScript to run web applications, emphasizing the necessity for a seamless user experience.

globenewswire.com

2 months ago

C4 Therapeutics to Present Data from the Ongoing Phase 1/2

C4 Therapeutics to present Phase 1/2 trial data on cemsidomide at ASH Annual Meeting, Dec 7-10, 2024, in San Diego. NHL data will be presented orally, and MM data as a poster. Updated data will be shared during the presentations on Dec 8th. C4T will also host a webcast on Dec 8th at 2 PM PT.

Related Clinical Trials:

Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy